VitaPCR™ SARS-CoV-2 RNA detection Assay can correctly detect Omicron sub-lineages BA.4 and BA.5
In response to the new Omicron variant (also known as B.1.1.529), we, Credo Diagnostics Biomedical Pte Ltd, have performed the BLASTn analysis (with the oligonucleotide primers and probes of the assays involving SARS-CoV-2 detection) against the sequences listed in GISAID on May 25th, 2022. According to our analysis, we confirm that our SARS-CoV-2 RNA detection […]
